Basis of Allotment

THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT.

wpe13E.jpg (10867 bytes) AMBEY LABORATORIES LIMITED
Corporate Identification Number: : U74899DL1985PLC020490

Our Company was originally incorporated as "Ambey Laboratories Private Limited' on March 20, 1985, as a Private Limited Company under the provisions of the Companies Act, 1956 bearing Corporate Identification Number U74899DL1985PTC020490 pursuant to Certificate of Incorporation issued by Registrar of Companies, Net of Delhi & Haryana. Subsequently, Our Company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of our Company at the Extra Ordinary General Meeting held on November 15th 2014 and name of our Company was changed to "Ambey Laboratories Limited' and a fresh Certificate of Incorporation dated December 30,2014, was issued by Registrar of Companies. NCT of Delhi & Haryana. The Company's Corporate Identification Number of our Company is U74899DL1985PLC020490.

Registered office: Ground Floor, Property No.555 Tarla Mohalla, Ghitorni, South West Delhi, New Delhi, Delhi, India -110030
Corporate Office: B18/9, DLF Phase -1 Sector 26A, Gurugram-122002, Gurugram, Haryana, India, 122002
Tel: 0124-4000788; E-mail: cs@ambeylab.com; Website: ambeylab.com ; Contact Person: Ms. Rimple Sarin, Company Secretary and Compliance Office
PROMOTERS OF THE COMPANY: ARCH IT GUPTA, ARPIT GUPTA, SARIN A GUPTA AND RISHITA GUPTA
BASIS OF ALLOTMENT

Our Company has filed the Prospectus dated July 09, 2024, (the 'Prospectus') with the Registrar of Companies, Delhi (ROC), and the equity shares (as defined here matter) arc proposed to be listed on the Emerge platform of National Stock Exchange of India Limited ["NSE') and the listing and trading of the Equity Shares (a defined hereinafter) expected to commence on July 11,2024.

BASIS OF ALLOTMENT

INITIAL PUBLIC OFFERING OF UP TO 65,70,000 EQUITY SHARES OF RS. 10/- EACH ("EQUITY SHARES") OF AMBEY LABORATORIES LIMITED ("AMBEY" OR THE "COMPANY") FOR CASH AT A PRICE OF RS. 68 /- PER EQUITY SHARE (THE "ISSUE PRICE"), AGGREGATING TO RS. 4,467.60 LAKHS ("THE OFFER"), COMPRISING A FRESH ISSUE OF UP TO 62,58,000 EQUITY SHARES AGGREGATING TO RS. 4,255.44 LAKHS BY OUR COMPANY ("FRESH ISSUE") AND AN OFFER FOR SALE OF UP TO 3,12,000 EQUITY SHARES BY MS. SARINA GUPTA ("THE PROMOTER GROUP UP SELLING SHAREHOLDERS' OR "THE SELLING SHAREHOLDER") AGGREGATING TO RS. 212.16 LAKHS ("OFFER FOR SALE"). OUT OF THE OFFER, 3,30,000 EQUITY SHARES AGGREGATING TO RS. 224.40 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER ("MARKET MAKER RESERVATION PORTION"). THE OFFER LESS THE MARKET MAKER RESERVATION PORTION I.E. OFFER OF 62,40,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH AT AN ISSUE PRICE OF RS. 681- PER EQUITY SHARE AGGREGATING TO RS. 4,243.20 LAKHS IS HEREINAFTER REFERRED TO AS THE "NET OFFER". THE OFFER AND THE NET OFFER WILL CONSTITUTE 26.34% AND 25.01%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY FOR FURTHER DETAILS, KINDLY REFER TO CHAPTER TITLED "TERMS OF THE ISSUE" BEGINNING ON PAGE 307 OF THE PROSPECTUS.

THE FACE VALUE OF THE EQUITY SHARE IS RS. 10/- EACH AND THE ISSUE PRICE IS RS.68.00/-
ANCHOR INVESTOR ISSUE PRICE: RS. 68/- PER EQUITY SHARE
THE ISSUE PRICE IS 6.8 TIMES OF THE FACE VALUE OF THE EQUITY SHARES.
ISSUE PERIOD BID/ISSUE OPENED ON: JULY 04, 2024 BID/ISSUE CLOSED ON: JULY 08, 2024 PROPOSED LISTING : JULY 11, 2024

* Subject to the receipt of listing and trading approval from NSE Emerge.

The Issue is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBIICDR Regulations and in compliance with Regulation 253 of SEBI (ICDR) Regulations, wherein not more than 50.00% of the Net Issue was made available for allocation on a proportionate basis to QIBs ("QIB Portion"). Further, not less than 15.00% of net issue was made available for allocation on proportionate basis to Non- Institutional Investors and not less than 35.00% of the Net Issue was made available for allocation to Retail Individual Bidders, in accordance with SEBI ICDR Regulations, subject to valid bids being received at the issue price. All potential Bidders are required to mandatorily utilize the Application Supported by Blocked Amount ("ASBA") process providing details of their respective ASBA accounts, and UPI ID in case of RIBs using the UPI Mechanism, if applicable, in which the corresponding Bid Amounts will be blocked by the SCSBs or by the Sponsor Bank under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Issue through the ASBA process. For details, see "Issue Procedure" beginning on page 317 of this Prospectus.

The Equity Shares offered through the Prospectus are proposed to be listed on Emerge Platform of NSE ("NSE Emerge") in terms of Chapter IX of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (the ‘‘SEBI (ICDR) regulations"), as amended read with rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended. Our company has received In Principle approval letter dated June 06, 2024, from National Stock Exchange of India Limited ("NSE") for using its name in the Offer Document for listing of our shares on Emerge Platform of NSE. It is to be distinctively understood that the permission given by National Stock Exchange of India Limited ("NSE") should not in any way be deemed or construed that the content of the Prospectus or the price at which equity shares are offered has been cleared, solicited or approved by NSE, nor does it certify the correctness, accuracy or completeness of any of the content of the Prospectus. The investors are advised to refer to the prospectus for the full text of the Disclaimer clause pertaining to NSE. For the purpose of this Issue, the Designated Stock Exchange will be National Stock Exchange of India Limited ("NSE"). The trading is proposed to commence on July 11,2024*.

*Subject to the listing and trading approval from Emerge Platform of NSE.

All Applicants were allowed to participate in the issue through APPLICATION SUPPORTED BY BLOCKED AMOUNT ("ASBA") process by providing the details of the respective bank accounts in which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the "SCSBs") or through UPI Mechanism.

SUBSCRIPTION DETAILS

The Company received 5 Anchor Investor Application Forms from 5 Anchor Investors (including Nil mutual funds through Nil Mutual Fund schemes) for 18,68,000 Equity Shares. Such 5 Anchor Investors through Anchor Investor Application Forms were allocated

DETAILS OF APPLICATIONS

The issue has received 229,199 applications, excluding Anchor Investors, (before technical rejections) for 707,006,000 equity shares resulting in subscription of 150.36 times (including reserved portion of Market Maker). The details of the applications received in the issue (before technical rejections but after applications not banked) are as follows:

Detail of the Applications Received:

Category

Before Technical Rejections & Withdrawals

After Technical Rejections & Withdrawals

No of Applications

No of equity shares

No of Applications

No of equity shares

Retail Individual Applicants

2,15,098

43,01,96,000

2,11,812

42,36,24,000

Non-institutional Investors

14,064

19,90,04,000

13,899

19,63,48,000

QIBs Category (Excluding Anchor Investor)

36

7,74,76,000

36

7,74,76,000

Market Maker

1

3,30,000

1

3,30,000

Total

2,29,199

70,70,06,000

2,25,748

69,77,78,000

Final Demand:

A summary of the final demand as at different Bid price is as under:

Sr. No.

Bid Price

No of Equity Shares

% of Total

Cumulative Total

Cumulative % of Total

1

65

1,208,000

0.15

1,208,000

0.15

2

66

588,000

0.07

1,796,000

0.22

3

67

622,000

0.07

2,418,000

0.29

4

68

564,100,000

67.84

566,518,000

68.14

5

9999

264,940,000

31.86

831,458,000

100.00

Total

83,14,58,000

100

-

-

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being NSE Emerge on June 09, 2024.

A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs. 68/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 3,30,000 Equity shares.

The category wise details of the Basis of Allotment are as under:

No. of Shares applied for (Category Wise)

Number of applications received

% to Total

Total No. of Shares applied in each category

% to Total

Ratio of allottees to applicants

Number of Successful applicants (after rounding off)

% to Total

Total No. of Shares allocated/ allotted

% to Total

3,30,000

1

100.00

3,30,000

100.00

1

1

1

100.00

3,30,000

100.00

1

100.00

3,30,000

100.00

1

100.00

3,30,000

100.00

B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs. 68/- per Equity Share, was finalized in consultation with NSE. The category was subscribed 193.97 times i.e. for 42,36,24,000 Equity Shares. Total number of shares allotted in this category is 21,84,000 Equity Shares.

The category wise details of the Basis of Allotment are as under:

No. of Shares applied for (Category Wise)

Number of applications received

% to Total

Total No. of Shares applied in each category

% to Total

Ratio of allottees to applicants

Number of Successful applicants (after rounding off)

Total No. of Shares allocated/ allotted

2000

211,812

100.00

423,624,000

100.00

1:194

1092

21,84,000

211,812

100.00

423,624,000

100.00

1092

21,84,000

C. Allocation to Other than Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to Other than Retail Individual Investors, at the issue price of Rs. 68/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 209.77 times i.e. application received for 19,63,48,000 equity shares & the total number of shares allotted in this category is 9.36,000 Equity Shares to 413 successful applicants.

The category wise details of the Basis of Allotment are as under (Sample basis):

ALLOCATION TO HNI

SUBSCRIPTION

209.7735

ALLOTEES

413

SHARES ALLOT

936000

Category

No. of Applications Received

%of Total

Total No. of Equity Shares Applied

% to Total

No. of Equity Shares Allotted per Bidder

Ratio

Total No. of Equity Shares Allotted

4,000

8378

60.28

33,512,000

17.07

2,000

80:8378

160,000

6,000

1694

12.19

10,164,000

5.18

2,000

24:1694

48,000

8,000

443

3.19

3,544,000

1.80

2,000

8:443

16,000

10,000

373

2.68

3,730,000

1.90

2,000

9:373

18,000

12,000

206

1.48

2,472,000

1.26

2,000

6:206

12,000

14,000

321

2.31

4,494,000

2.29

2,000

11:321

22,000

16,000

937

6.74

14,992,000

7.64

2,000

36:937

72,000

18,000

184

1.32

3,312,000

1.69

2,000

8:184

16,000

20,000

334

2.40

6,680,000

3.40

2,000

16:334

32,000

22,000

111

0.80

2,442,000

1.24

2,000

6:111

12,000

24,000

70

0.50

1,680,000

0.86

2,000

4:70

8,000

26,000

40

0.29

1,040,000

0.53

2,000

2:40

4,000

28,000

57

0.41

1,596,000

0.81

2,000

4:57

8,000

30,000

128

0.92

3,840,000

1.96

2,000

9:128

18,000

32,000

31

0.22

992,000

0.51

2,000

2:31

4,000

34,000

19

0.14

646,000

0.33

2,000

2:19

4,000

36,000

50

0.36

1,800,000

0.92

2,000

4:50

8,000

38,000

21

0.15

798,000

0.41

2,000

2:21

4,000

40,000

56

0.40

2,240,000

1.14

2,000

5:56

10,000

42,000

14

0.10

588,000

0.30

2,000

1:14

2,000

44,000

15

0.11

660,000

0.34

2,000

2:15

4,000

46,000

10

0.07

460,000

0.23

2,000

1:10

2,000

48,000

6

0.04

288,000

0.15

2,000

1:6

2,000

50,000

19

0.14

950,000

0.48

2,000

2:19

4,000

52,000

5

0.04

260,000

0.13

2,000

1:5

2,000

54,000

4

0.03

216,000

0.11

2,000

1:4

2,000

56,000

5

0.04

280,000

0.14

2,000

1:5

2,000

58,000

6

0.04

348,000

0.18

2,000

1:6

2,000

60,000

25

0.18

1,500,000

0.76

2,000

4:25

8,000

62,000

7

0.05

434,000

0.22

2,000

1:7

2,000

64,000

3

0.02

192,000

0.10

2,000

0:3

0

66,000

1

0.01

66,000

0.03

2,000

0:1

0

68,000

5

0.04

340,000

0.17

2,000

1:5

2,000

70,000

5

0.04

350,000

0.18

2,000

1:5

2,000

72,000

13

0.09

936,000

0.48

2,000

2:13

4,000

74,000

14

0.10

1,036,000

0.53

2,000

2:14

4,000

76,000

8

0.06

608,000

0.31

2,000

1:8

2,000

78,000

1

0.01

78,000

0.04

2,000

0:1

0

80,000

9

0.06

720,000

0.37

2,000

2:9

4,000

82,000

3

0.02

246,000

0.13

2,000

1:3

2,000

86,000

3

0.02

258,000

0.13

2,000

1:3

2,000

88,000

2

0.01

176,000

0.09

2,000

0:2

0

90,000

5

0.04

450,000

0.23

2,000

1:5

2,000

92,000

2

0.01

184,000

0.09

2,000

0:2

0

94,000

10

0.07

940,000

0.48

2,000

2:10

4,000

96,000

2

0.01

192,000

0.10

2,000

0:2

0

98,000

1

0.01

98,000

0.05

2,000

0:1

0

100,000

15

0.11

1,500,000

0.76

2,000

4:15

8,000

102,000

5

0.04

510,000

0.26

2,000

1:5

2,000

106,000

1

0.01

106,000

0.05

2,000

0:1

0

108,000

3

0.02

324,000

0.17

2,000

1:3

2,000

110,000

2

0.01

220,000

0.11

2,000

1:2

2,000

112,000

1

0.01

112,000

0.06

2,000

0:1

0

116,000

2

0.01

232,000

0.12

2,000

1:2

2,000

118,000

1

0.01

118,000

0.06

2,000

0:1

0

120,000

7

0.05

840,000

0.43

2,000

2:7

4,000

122,000

2

0.01

244,000

0.12

2,000

1:2

2,000

124,000

3

0.02

372,000

0.19

2,000

1:3

2,000

126,000

1

0.01

126,000

0.06

2,000

0:1

0

128,000

4

0.03

512,000

0.26

2,000

1:4

2,000

130,000

1

0.01

130,000

0.07

2,000

0:1

0

132,000

3

0.02

396,000

0.20

2,000

1:3

2,000

136,000

1

0.01

136,000

0.07

2,000

0:1

0

140,000

4

0.03

560,000

0.29

2,000

1:4

2,000

142,000

1

0.01

142,000

0.07

2,000

0:1

0

144,000

2

0.01

288,000

0.15

2,000

1:2

2,000

146,000

19

0.14

2,774,000

1.41

2,000

7:19

14,000

148,000

18

0.13

2,664,000

1.36

2,000

6:18

12,000

150,000

6

0.04

900,000

0.46

2,000

2:6

4,000

152,000

2

0.01

304,000

0.15

2,000

1:2

2,000

154,000

3

0.02

462,000

0.24

2,000

1:3

2,000

156,000

1

0.01

156,000

0.08

2,000

0:1

0

158,000

3

0.02

474,000

0.24

2,000

1:3

2,000

160,000

1

0.01

160,000

0.08

2,000

0:1

0

166,000

2

0.01

332,000

0.17

2,000

1:2

2,000

168,000

1

0.01

168,000

0.09

2,000

0:1

0

170,000

2

0.01

340,000

0.17

2,000

1:2

2,000

178,000

2

0.01

356,000

0.18

2,000

1:2

2,000

184,000

1

0.01

184,000

0.09

2,000

0:1

0

186,000

2

0.01

372,000

0.19

2,000

1:2

2,000

190,000

1

0.01

190,000

0.10

2,000

0:1

0

196,000

1

0.01

196,000

0.10

2,000

0:1

0

200,000

4

0.03

800,000

0.41

2,000

2:4

4,000

208,000

1

0.01

208,000

0.11

2,000

0:1

0

212,000

2

0.01

424,000

0.22

2,000

1:2

2,000

218,000

1

0.01

218,000

0.11

2,000

1:1

2,000

220,000

3

0.02

660,000

0.34

2,000

2:3

4,000

222,000

2

0.01

444,000

0.23

2,000

1:2

2,000

226,000

3

0.02

678,000

0.35

2,000

2:3

4,000

230,000

2

0.01

460,000

0.23

2,000

1:2

2,000

240,000

1

0.01

240,000

0.12

2,000

1:1

2,000

242,000

1

0.01

242,000

0.12

2,000

1:1

2,000

246,000

1

0.01

246,000

0.13

2,000

1:1

2,000

252,000

1

0.01

252,000

0.13

2,000

1:1

2,000

256,000

1

0.01

256,000

0.13

2,000

1:1

2,000

266,000

1

0.01

266,000

0.14

2,000

1:1

2,000

270,000

1

0.01

270,000

0.14

2,000

1:1

2,000

272,000

2

0.01

544,000

0.28

2,000

1:2

2,000

274,000

1

0.01

274,000

0.14

2,000

1:1

2,000

278,000

1

0.01

278,000

0.14

2,000

1:1

2,000

280,000

2

0.01

560,000

0.29

2,000

1:2

2,000

282,000

1

0.01

282,000

0.14

2,000

1:1

2,000

290,000

1

0.01

290,000

0.15

2,000

1:1

2,000

292,000

1

0.01

292,000

0.15

2,000

1:1

2,000

300,000

2

0.01

600,000

0.31

2,000

1:2

2,000

306,000

1

0.01

306,000

0.16

2,000

1:1

2,000

308,000

1

0.01

308,000

0.16

2,000

1:1

2,000

310,000

1

0.01

310,000

0.16

2,000

1:1

2,000

314,000

1

0.01

314,000

0.16

2,000

1:1

2,000

332,000

1

0.01

332,000

0.17

2,000

1:1

2,000

336,000

1

0.01

336,000

0.17

2,000

1:1

2,000

338,000

1

0.01

338,000

0.17

2,000

1:1

2,000

340,000

1

0.01

340,000

0.17

2,000

1:1

2,000

354,000

1

0.01

354,000

0.18

2,000

1:1

2,000

358,000

2

0.01

716,000

0.36

2,000

1:1

4,000

360,000

4

0.03

1,440,000

0.73

2,000

3:4

6,000

362,000

1

0.01

362,000

0.18

2,000

1:1

2,000

366,000

1

0.01

366,000

0.19

2,000

1:1

2,000

368,000

3

0.02

1,104,000

0.56

2,000

1:1

6,000

380,000

1

0.01

380,000

0.19

2,000

1:1

2,000

390,000

1

0.01

390,000

0.20

2,000

1:1

2,000

396,000

1

0.01

396,000

0.20

2,000

1:1

2,000

416,000

1

0.01

416,000

0.21

2,000

1:1

2,000

422,000

1

0.01

422,000

0.21

2,000

1:1

2,000

428,000

1

0.01

428,000

0.22

2,000

1:1

2,000

436,000

1

0.01

436,000

0.22

2,000

1:1

2,000

440,000

2

0.01

880,000

0.45

2,000

1:1

4,000

442,000

3

0.02

1,326,000

0.68

2,000

1:1

6,000

450,000

3

0.02

1,350,000

0.69

2,000

1:1

6,000

456,000

1

0.01

456,000

0.23

2,000

1:1

2,000

458,000

1

0.01

458,000

0.23

2,000

1:1

2,000

466,000

1

0.01

466,000

0.24

2,000

1:1

2,000

474,000

1

0.01

474,000

0.24

2,000

1:1

2,000

476,000

1

0.01

476,000

0.24

2,000

1:1

2,000

482,000

1

0.01

482,000

0.25

2,000

1:1

2,000

494,000

2

0.01

988,000

0.50

2,000

1:1

4,000

498,000

1

0.01

498,000

0.25

2,000

1:1

2,000

500,000

2

0.01

1,000,000

0.51

2,000

1:1

4,000

502,000

2

0.01

1,004,000

0.51

2,000

1:1

4,000

504,000

1

0.01

504,000

0.26

2,000

1:1

2,000

512,000

1

0.01

512,000

0.26

2,000

1:1

2,000

514,000

1

0.01

514,000

0.26

2,000

1:1

2,000

516,000

1

0.01

516,000

0.26

2,000

1:1

2,000

538,000

1

0.01

538,000

0.27

2,000

1:1

2,000

540,000

1

0.01

540,000

0.28

2,000

1:1

2,000

546,000

1

0.01

546,000

0.28

2,000

1:1

2,000

560,000

1

0.01

560,000

0.29

2,000

1:1

2,000

588,000

1

0.01

588,000

0.30

2,000

1:1

2,000

590,000

1

0.01

590,000

0.30

2,000

1:1

2,000

600,000

1

0.01

600,000

0.31

2,000

1:1

2,000

610,000

1

0.01

610,000

0.31

2,000

1:1

2,000

614,000

1

0.01

614,000

0.31

2,000

1:1

2,000

628,000

1

0.01

628,000

0.32

2,000

1:1

2,000

646,000

1

0.01

646,000

0.33

4,000

1:1

4,000

650,000

1

0.01

650,000

0.33

4,000

1:1

4,000

674,000

1

0.01

674,000

0.34

4,000

1:1

4,000

700,000

1

0.01

700,000

0.36

4,000

1:1

4,000

734,000

1

0.01

734,000

0.37

4,000

1:1

4,000

736,000

1

0.01

736,000

0.37

4,000

1:1

4,000

780,000

2

0.01

1,560,000

079

4,000

1:1

8,000

820,000

1

0.01

820,000

0.42

4,000

1:1

4,000

936,000

1

0.01

936,000

0.48

4,000

1:1

4,000

964,000

1

0.01

964,000

0.49

4,000

1:1

4,000

1,070,000

1

0.01

1,070,000

0.54

6,000

1:1

6,000

1,076,000

1

0.01

1,076,000

0.55

6,000

1:1

6,000

1,470,000

1

0.01

1,470,000

0.75

8,000

1:1

8,000

',548,000

1

0.01

1,548,000

079

8,000

1:1

8,000

2,790,000

6

0.04

16,740,000

8.53

12,000

1:1

72,000

2000 additional share is allocated for Serial no 168 in the ratio of 4:6

2,000

4:6

8,000

TOTAL

13899

100.00

196348000

100.00

936000

D. Allocation to QIB Category (Excluding Anchor Investor)

Allotment to QIB. who have bid at the issue price of Rs.68/- per Equity Share, was finalized in consultation with NSE. The Basis of the Issue has received 36 Applications for 7,74,76,000 equity shares, whereas 1.58,000 shares were reserved for Mutual Funds. The allotment was made to 36 applicants for 12,52,000 equity shares.

The category wise details of the Basis of Allotment are as under:

CATEGORY

FIS/BANKS

MF'S

IC'S

NBFC'S

AIF

FPC

VC'S

TOTAL

ALLOTMENT

104,000

34,000

490,000

178,000

392,000

54,000

1,252,000

E. Allocation to Anchor Investor (After Technical Rejection):

The company in consultation v/ith BRLM had allotted 18,68.000 Equity Shares to 5 (Five) Anchor Investor at an Issue price of Rs. 68/- per share in accordance with SEBI (ICDR) Regulations. 2018.

The category wise details of the Basis of Allotment are as under:

CATEGORY

FIS/BANKS

MF'S

IC'S

NBFC'S

AIF

FPC

OTHERS

TOTAL

ALLOTMENT

1,172,000

696,000

1,868,000

The Board of Directors of the Company at its meeting held on July 09, 2024, has approved the Basis of Allocation of Equity Shares as approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for issue of the Equity Shares to various successful applicants.

The CAN-cum-allotment advices and/or notices will be 'orwarded to the email id's and add'ess of the Aoplicants as registered with the depositories / as filled in the app icat on form on or before July 09. 2024. Further, the instructions to Self-Certified Syndicate Banks for unblocking the amount will be processed on or prior to July 10, 2024. In case the same is no: rece ved within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are Deing credited to their beneficiary accounts subject to va idation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the Emerge Platform of NSE Limited (NSE Emerge) within three working days from the date of the closure of the issue.

Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus dated July 09,2024 ("Prospectus")

INVESTORS PLEASE NOTE

The details of the allotment made would also be hosted on the website of the Registrar to the issue, LINK INTIME INDIA PRIVATE LIMITED at www.linkintime.co.in All future correspondence in this regard may kindly be addressed to the Reg strar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Register given below:

wpe13D.jpg (4375 bytes) LINK INTIME INDIA PRIVATE LIMITED
Address: C-101,1" Floor, 247 Park, Lai Bahadur, Shastri Marg, Vikhroli (West) Mumbai, Maharashtra - 400083, India
Telephone: +91 8108114949;
Email: ambeylab.ipo@Linkintime.co.in
Website: www.linkintime.co.in:
Contact Person: Ms. Shanti Gopalkrishnan
SEBI Registration Number: INR000004058; CIN: U67190MH1999PTC118368

 

For AMBEY LABORATORIES LIMITED

On Behalf of the Board of Directors

Sd /-

Sarina Gupta

Place: Delhi

(Whole Time Director)

Date: 10.07.2024

DIN: 08787098

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF AMBEY LABORATORIES LIMITED.

Note: All capitalized terms used and not defined herein shall have same meanings assigned to them in the Prospectus.

Disclaimer: AMBEY LABORATORIES LIMITED has filed the Prospectus with ROC on July 09,2024, and thereafter with SEBI and Stock Exchanges. The Prospectus is available on the Website of LM, Fast Track Finsec Private Limited at www.ftfinsec.com . Investors should note that investment Equity Shares involve a high degree of risk and for details relating to the same, please see "Risk Factor" beginning on page 33 of the Prospectus.

The Equity Shares have not been and will not be registered under U.S. Securities Act of 1993, as amended ("the Securities Act") or any state securities laws in the United States, and unless so registered, and may not be offered or sold within United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with any applicable U.S. state securities laws. The Equity Shares are being offered and sold outside the United States in ‘offshore transactions' in reliance on Regulations under Securities Act and the applicable laws of each jurisdiction where such offers and sales were made. There will be no public offering in the United States.

Close